Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson’s disease: study rationale and protocol

BACKGROUND: Parkinson’s disease (PD) is a neurodegenerative disease, for which no disease-modifying therapies exist. Preclinical and clinical evidence suggest that hypoxia-based therapy might have short- and long-term benefits in PD. We present the contours of the first study to assess the safety, f...

Descripción completa

Detalles Bibliográficos
Autores principales: Janssen Daalen, Jules M., Meinders, Marjan J., Giardina, Federica, Roes, Kit C. B., Stunnenberg, Bas C., Mathur, Soania, Ainslie, Philip N., Thijssen, Dick H. J., Bloem, Bastiaan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281145/
https://www.ncbi.nlm.nih.gov/pubmed/35836147
http://dx.doi.org/10.1186/s12883-022-02770-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281145/
https://www.ncbi.nlm.nih.gov/pubmed/35836147
http://dx.doi.org/10.1186/s12883-022-02770-7

Ejemplares similares